EBMT 2020 | Significance of MRD negativity in Ph-negative ALL
Ivan Moiseev
• 1 Sep 2020
Ivan Moiseev, MD, PhD, First Saint Petersburg State Medical University, Saint Petersburg, Russia, explores factors predicting the outcome of allogeneic stem cell transplantation in patients with Philadelphia chromosome-negative (Ph-negative) acute lymphoblastic leukemia (ALL), with the main predictor being minimal residual disease (MRD) negativity. Dr. Moiseev outlines strategies to achieve MRD negative remission including treating with agents such as blinotuzumab, inotuzumab as well as CAR T-cell therapies. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
